Actimmune — Highmark
Chronic Granulomatous Disease (CGD)
Initial criteria
- Diagnosis of Chronic Granulomatous Disease (CGD)
- Prescriber attests the member will use Actimmune to reduce the frequency and severity of serious infections
Approval duration
12 months